Impaired antioxidative activity of high-density lipoprotein is associated with more severe acute ischemic stroke

Diabetes - General

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort

J Diabetes.

Zhang N, Hu X, Zhang Q, Bai P, Cai M, Zeng TS, Zhang JY, Tian SH, Min J, Huang HT, Zheng J, Peng MM, Li MJ, Chen LL

doi: 10.1111/1753-0407.12650.

HypogonadismLipids

High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism

J Clin Endocrinol Metab.

Adorni MP, Zimetti F, Cangiano B, Vezzoli V, Bernini F, Caruso D, Corsini A, Sirtori CR, Cariboni A, Bonomi M, Ruscica M

doi: 10.1210/jc.2018-02027.

Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl

Am J Cardiol.

Piao ZH, Jin L, Kim JH, Ahn Y, Kim YJ, Cho MC, Kim CJ, Kim HS, Liu B, Jeong MH; Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators

doi: 10.1016/j.amjcard.

COMMENTED

Type 2 Diabetes

Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

JAMA Cardiol.

Lotta LA, Stewart ID, Sharp SJ, Day FR, Burgess S, Luan J, Bowker N, Cai L, Li C, Wittemans LBL, Kerrison ND, Khaw KT, McCarthy MI, O'Rahilly S, Scott RA, Savage DB, Perry JRB, Langenberg C, Wareham NJ

doi: 10.1001/jamacardio.

Pediatric Diabetes

The Association of Low-Density Lipoprotein Cholesterol with Elevated Arterial Stiffness in Adolescents and Young Adults with type 1 and type 2 Diabetes: The SEARCH for Diabetes in Youth Study

Pediatr Diabetes.

Gourgari E, Stafford JM, D'Agostino R Jr, Dolan LM, Lawrence JM, Marcovina S, Merjaneh L, Mottl AK, Shah AS, Dabelea D

doi: 10.1111/pedi.13021.

Diabetes - GeneralType 2 Diabetes

Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis

JAMA.

Lotta LA, Sharp SJ, Burgess S, Perry JR, Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B, Boeing H, Deloukas P, Forouhi NG, Franks PW, Grioni S, Kaaks R, Key TJ, Navarro C, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Riboli E, Rolandsson O, Sacerdote C, Salamanca-Fernandez E, Slimani N, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, McCarthy MI, Barroso I, O'Rahilly S, Savage DB, Sattar N, Langenberg C, Scott RA, Wareham NJ

doi: 10.1001/jama.2016.14568.

COMMENTED

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Circulation.

Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS

doi: 10.1161/CIRCULATIONAHA.

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

JAMA.

Ference BA, Kastelein JJP, Ginsberg HN, Chapman MJ, Nicholls SJ, Ray KK, Packard CJ, Laufs U9, Brook RD, Oliver-Williams C, Butterworth AS, Danesh J, Smith GD, Catapano AL, Sabatine MS

doi: 10.1001/jama.2017.11467.

Obesity and Bariatric Surgery

BMI increase through puberty and adolescence is associated with risk of adult stroke

Neurology.

Ohlsson C, Bygdell M, Sondén A, Jern C, Rosengren A, Kindblom JM

doi: 10.1212/

Related content